Negative feedback on IL-23 exerted by IL-17A during pulmonary inflammation
-
- Elin Silverpil
- Lung Immunology Group, Department of Internal Medicine and Clinical Nutrition/Respiratory Medicine and Allergology, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
-
- Adam KA Wright
- Biomedical Research Centre in Microbial Diseases, National institute of Health Research, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK
-
- Marit Hansson
- Lung Immunology Group, Department of Internal Medicine and Clinical Nutrition/Respiratory Medicine and Allergology, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
-
- Pernilla Jirholt
- Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
-
- Louise Henningsson
- Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
-
- Margaretha E Smith
- Lung Immunology Group, Department of Internal Medicine and Clinical Nutrition/Respiratory Medicine and Allergology, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
-
- Stephen B Gordon
- Respiratory Infection Group, Liverpool School of Tropical Medicine, Liverpool, UK
-
- Yoichiro Iwakura
- Center for Experimental Medicine and Systems Biology, Institute of Medical Science, University of Tokyo, and Core Research for Evolutional Science and Technology (CREST), Tokyo, Japan
-
- Inger Gjertsson
- Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
-
- Pernilla Glader
- Lung Immunology Group, Department of Internal Medicine and Clinical Nutrition/Respiratory Medicine and Allergology, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
-
- Anders Lindén
- Unit for Lung and Airway Research, Physiology Division, Institute for Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
この論文をさがす
説明
<jats:p> It is now established that IL-17 has a broad pro-inflammatory potential in mammalian host defense, in inflammatory disease and in autoimmunity, whereas little is known about its anti-inflammatory potential and inhibitory feedback mechanisms. Here, we examined whether IL-17A can inhibit the extracellular release of IL-23 protein, the upstream regulator of IL-17A producing lymphocyte subsets, that is released from macrophages during pulmonary inflammation. We characterized the effect of IL-17A on IL-23 release in several models of pulmonary inflammation, evaluated the presence of IL-17 receptor A (RA) and C (RC) on human alveolar macrophages and assessed the role of the Rho family GTPase Rac1 as a mediator of the effect of IL-17A on the release of IL-23 protein. In a model of sepsis-induced pneumonia, intravenous exposure to Staphylococcus aureus caused higher IL-23 protein concentrations in cell-free bronchoalveolar lavage (BAL) samples from IL-17A knockout (KO) mice, compared with wild type (WT) control mice. In a model of Gram-negative airway infection, pre-treatment with a neutralizing anti-IL-17A Ab and subsequent intranasal (i.n.) exposure to LPS caused higher IL-23 and IL-17A protein concentrations in BAL samples compared with mice exposed to LPS, but pre-treated with an isotype control Ab. Moreover, i.n. exposure with IL-17A protein per se decreased IL- 23 protein concentrations in BAL samples. We detected IL-17RA and IL-17RC on human alveolar macrophages, and found that in vitro stimulation of these cells with IL-17A protein, after exposure to LPS, decreased IL-23 protein in conditioned medium, but not IL-23 p19 or p40 mRNA. This study indicates that IL-17A can partially inhibit the release of IL-23 protein during pulmonary inflammation, presumably by stimulating the here demonstrated receptor units IL-17RA and IL-17RC on alveolar macrophages. Hypothetically, the demonstrated mechanism may serve as negative feedback to protect from excessive IL-17A signaling and to control antibacterial host defense once it is activated. </jats:p>
収録刊行物
-
- Innate Immunity
-
Innate Immunity 19 (5), 479-492, 2013-01-07
SAGE Publications
- Tweet
キーワード
- Feedback, Physiological
- Lipopolysaccharides
- Mice, Knockout
- rac1 GTP-Binding Protein
- Mice, Inbred BALB C
- Staphylococcus aureus
- Receptors, Interleukin-17
- Interleukin-17
- Pneumonia
- Receptors, Interleukin
- Staphylococcal Infections
- Interleukin-23
- Mice, Inbred C57BL
- Mice
- Macrophages, Alveolar
- Animals
- Antibodies, Blocking
- Cells, Cultured
詳細情報 詳細情報について
-
- CRID
- 1360285711706861568
-
- ISSN
- 17534267
- 17534259
-
- PubMed
- 23295184
-
- 資料種別
- journal article
-
- データソース種別
-
- Crossref
- KAKEN
- OpenAIRE